| Year |
Citation |
Score |
| 2015 |
Voshavar C, Shah M, Xu L, Dutta AK. Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease. Neurotoxicity Research. 28: 302-18. PMID 26201265 DOI: 10.1007/S12640-015-9548-6 |
0.639 |
|
| 2014 |
Modi G, Voshavar C, Gogoi S, Shah M, Antonio T, Reith ME, Dutta AK. Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates. Acs Chemical Neuroscience. 5: 700-17. PMID 24960209 DOI: 10.1021/Cn500084X |
0.599 |
|
| 2014 |
Shah M, Rajagopalan S, Xu L, Voshavar C, Shurubor Y, Beal F, Andersen JK, Dutta AK. The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Journal of Neurochemistry. 131: 74-85. PMID 24848702 DOI: 10.1111/Jnc.12767 |
0.683 |
|
| 2014 |
Killinger B, Shah M, Moszczynska A. Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats. Journal of Neurochemistry. 128: 764-75. PMID 24151877 DOI: 10.1111/Jnc.12496 |
0.308 |
|
| 2013 |
Santra S, Xu L, Shah M, Johnson M, Dutta A. D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson's disease animal model. Acs Chemical Neuroscience. 4: 1382-92. PMID 23906010 DOI: 10.1021/Cn400106N |
0.673 |
|
| 2013 |
Angoa-Pérez M, Kane MJ, Briggs DI, Francescutti DM, Sykes CE, Shah MM, Thomas DM, Kuhn DM. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. Journal of Neurochemistry. 125: 102-10. PMID 23205838 DOI: 10.1111/Jnc.12114 |
0.404 |
|
| 2013 |
Shah M, Voshavar C, Xu L, Modi G, Dutta A. Evaluation of multifunctional dopamine agonists in modulation of alpha-synuclein induced aggregation and toxicity: implication in neuroprotective treatment of Parkinson's disease F1000research. 4. DOI: 10.7490/F1000Research.1094643.1 |
0.583 |
|
| 2012 |
Angoa-Pérez M, Kane MJ, Francescutti DM, Sykes KE, Shah MM, Mohammed AM, Thomas DM, Kuhn DM. Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. Journal of Neurochemistry. 120: 1097-107. PMID 22191803 DOI: 10.1111/J.1471-4159.2011.07632.X |
0.419 |
|
| 2010 |
Thomas DM, Angoa Pérez M, Francescutti-Verbeem DM, Shah MM, Kuhn DM. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum. Journal of Neurochemistry. 115: 595-605. PMID 20722968 DOI: 10.1111/J.1471-4159.2010.06950.X |
0.363 |
|
| Show low-probability matches. |